TREM2 and Alzheimer disease: Furthermore, mTORC1 activation in activated microglia has a significant role in phagocytosis, since rapamycin treatment decreases TREM2 expression in microglia and the clearance of β-Amyloid plaques in an Alzheimer’s disease mouse model [31].